Search results
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the...
Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30%
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine...
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
Let the Market’s Shakeout Finish Before Buying Novavax Stock
InvestorPlace via Yahoo Finance· 2 years agoNovavax (NVAX) stock traders may be tempted to buy the dip after a share-price crash. Yet,...
Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) closed at $51.67 in the latest trading session, marking a -0.27% move from the prior...
Novavax (NVAX) Q2 Earnings Miss, Cuts '22 Sales Guidance by Half
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) reports dismal results in second-quarter 2022. The stock dives in after-market...
Novavax, Inc. (NASDAQ:NVAX) surges 16%; individual investors who own 57% shares profited along with...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Novavax, Inc. (NASDAQ:NVAX) should be aware of the most powerful shareholder...
Novavax, Inc. (NASDAQ:NVAX) Shares Fly 54% But Investors Aren't Buying For Growth
Simply Wall St. via Yahoo Finance· 1 year agoNovavax, Inc. (NASDAQ:NVAX) shareholders are no doubt pleased to see that the share price has...
Novavax (NVAX) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoWe expect investors to focus on the sales performance of Novavax, Inc.’s NVAX protein-based COVID-19...